Skip to main content

Advertisement

SpringerLink
Log in

Histopathological and ultrastructural monitoring of remission induction in crescentic C3 glomerulonephritis

  • Lessons for the Clinical Nephrologist
  • Published:
Journal of Nephrology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Data availability statement

Deidentified data are available on reasonable request from the corresponding author.

References

  1. Yadav P et al (2015) The use of immunoglobulin light chain assays in the diagnosis of paraprotein-related kidney disease. Kidney Int 87(4):692–697

    Article  CAS  Google Scholar 

  2. Pickering MC et al (2013) C3 glomerulopathy: consensus report. Kidney Int 84(6):1079–1089

    Article  Google Scholar 

  3. Servais A et al (2012) Acquired and genetic complement abnormalities play a critical role in dense deposit disease and other C3 glomerulopathies. Kidney Int 82(4):454–464

    Article  CAS  Google Scholar 

  4. Goodship TH et al (2017) Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a “Kidney Disease: improving Global Outcomes” (KDIGO) Controversies Conference. Kidney Int 91(3):539–551

    Article  CAS  Google Scholar 

  5. de Lind van Wijngaarden RAF et al (2007) Chances of renal recovery for dialysis-dependent ANCA-associated glomerulonephritis. J Am Soc Nephrol 18(7):2189–2197

    Article  Google Scholar 

  6. Little MA et al (2010) Early mortality in systemic vasculitis: relative contribution of adverse events and active vasculitis. Ann Rheum Dis 69(6):1036–1043

    Article  Google Scholar 

  7. Hoffman GS et al (1992) Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med 116(6):488–498

    Article  CAS  Google Scholar 

  8. van Daalen EE et al (2017) Effect of rituximab on malignancy risk in patients with ANCA-associated vasculitis. Ann Rheum Dis 76(6):1064–1069

    Article  Google Scholar 

Download references

Acknowledgements

The authors thank Ulrike Ehbrecht and Kerstin Brekerbohm for technical assistance.

Funding

This research was supported by the Research program, University Medical Center, University of Göttingen, grant number 1403720. We also acknowledge support by the Open Access Publication Funds of the Georg August University Göttingen.

Author information

Authors and Affiliations

  1. Institute of Pathology, University Medical Center Göttingen, Göttingen, Germany

    Samy Hakroush & Ann-Kathrin Gersmann

  2. Department of Nephrology and Rheumatology, University Medical Center Göttingen, Göttingen, Germany

    Björn Tampe

Authors
  1. Samy Hakroush
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ann-Kathrin Gersmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Björn Tampe
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

BT conceived the study, collected and analyzed data and wrote the first draft. AKG and SH evaluated histopathological findings. AKG and SH edited the manuscript. BT was directly involved in the treatment of the patient.

Corresponding author

Correspondence to Björn Tampe.

Ethics declarations

Conflict of interest

SH, AKG and BT have no conflicts of interest to report.

Ethical approval

The study was conducted according to the guidelines of the Declaration of Helsinki and approved by the Ethics Committee of the University Medical Center Göttingen (protocol code 28/9/17).

Patient and public involvement

Patients and/or the public were not involved in the design, or conduct, or reporting or dissemination plans of this research.

Patient consent for publication

Written informed consent to publish this report was obtained from the patient.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hakroush, S., Gersmann, AK. & Tampe, B. Histopathological and ultrastructural monitoring of remission induction in crescentic C3 glomerulonephritis. J Nephrol 35, 1259–1263 (2022). https://doi.org/10.1007/s40620-021-01169-w

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40620-021-01169-w

Keyword

Search

Navigation